The drug is indicated for use by adults for:
Prevention of venous thromboembolic complications in surgical patients with moderate and high risk, especially in patients who are subject to orthopedic or General surgical surgery, including surgery for cancer.
Prevention of venous thromboembolic complications in therapeutic patients with acute diseases (such as acute heart failure, respiratory failure, severe infections or rheumatic diseases) and reduced mobility, who have an increased risk of venous thromboembolism.
Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), except in cases of PE, in which thrombolytic therapy or surgery may be necessary.
Prevention of blood clots in extracorporeal circulation during hemodialysis.
In acute coronary syndrome:
for the treatment of unstable angina and myocardial infarction without St segment elevation( NSTEMI), in combination with oral administration of acetylsalicylic acid;
for the treatment of acute ST-segment elevation myocardial infarction (STEMI), including in patients who are scheduled for medication or further percutaneous coronary intervention (PCI).